Press Releases

Toronto, Ontario, July 10, 2023 – Predictmedix (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI), announced today that it will be changing its corporate name to Predictmedix AI Inc, aligning the company’s brand image with its innovative and AI-driven approach […]

Toronto, Ontario, June 21, 2023 – Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI), announces the closing of its previously announced private placement. The Company has issued 10,510,000 units (the “Units”) at a price of $0.10 per unit […]

  Key ongoing discussions with Government officials for scaling Safe Entry’s multiple healthcare applications Ongoing partnership with prestigious Indonesian university for validation of Safe Entry as part of medical device regulatory approval process Significant updates to Safe Entry’s technology suite and broad healthcare applications   Toronto, Ontario – June 13, 2023 – Predictmedix Inc. (“Predictmedix” […]

Toronto, Ontario – May 17, 2023 – Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI), is proud to announce the launch of its ground-breaking fitness scan vertical tailored specifically for athletes, teams, and sports federations. Leveraging state-of-the-art AI […]

Toronto, Ontario – May 10, 2023 – Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI), is proud to announce the launch of its ground-breaking complete triage solution. Predictmedix’s cutting-edge system encompasses a wide range of parameters, including 8 […]

Toronto, Ontario – April 19, 2023 – Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI), is proud to announce a significant advancement in its Safe Entry Stations. The Company’s AI-powered screening technology will now be able to take […]

Toronto, Ontario – March 30, 2023 – Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI), today announced a purchase order from one of the largest Government hospital groups in India, MGM Healthcare, for the company’s AI-powered Safe Entry […]

Toronto, Ontario – March 28, 2023 – Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI), is thrilled to announce that it’s AI-powered technology, powering the Safe Entry Station, was Featured in a major Indonesian newspaper published on March […]

Toronto, Ontario – March 23, 2023 – Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI) is excited to announce an update on the functionality and application of their technology across specific verticals. The update comes after the Company’s […]

  Toronto, Ontario – March 20, 2023 – Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI), announced today that the US Patent Office has granted a patent for its AI-powered technology (United States Patent Application Number: 16/892,369) for […]

  Predictmedix has begun production of its mobile application for detecting impairment from cannabis and alcohol Predictmedix’s screening to identify impairment takes less than 30 seconds The mobile application, powered by AI algorithms currently being utilized in Safe Entry will be accompanied by a “mini” multi-spectral imaging camera resulting in a portable non-invasive impairment detection […]

The 1600-person study at a prestigious University in Jakarta, Indonesia prepares Predictmedix’s Safe Entry for regulatory approval listed as a ‘Medical Device’   Medical device classification allows Predictmedix to commercialize Safe Entry at scale in Indonesia   Third-party clinical validation yet another milestone for Predictmedix’s AI-Powered screening technology   Toronto, Ontario, March 8, 2023 – […]